Nath Bio-Genes (India) Limited (NATHBIOGEN.NS)

INR 196.3

(1.64%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 8.8 Billion 7.92 Billion 7.41 Billion 7.89 Billion 7.29 Billion 6.46 Billion
Total Current Assets 5.71 Billion 5.2 Billion 4.7 Billion 5.23 Billion 4.77 Billion 4.07 Billion
Cash And Short Term Investments 774.09 Million 2.08 Billion 41.68 Million 292.11 Million 219.79 Million 213.79 Million
Cash and Cash Equivalents 774.09 Million 379.95 Million 41.68 Million 292.11 Million 219.79 Million 213.79 Million
Short Term Investments 1.62 Billion 1.7 Billion 152 Thousand -325.00 215 Million 200 Million
Net Receivables 943.08 Million 1.03 Billion 2.45 Billion 2.68 Billion 1.1 Billion 2.3 Billion
Inventory 2.3 Billion 2.07 Billion 2.2 Billion 2.26 Billion 2.04 Billion 1.55 Billion
Other Current Assets 1.69 Billion 6.98 Million 2000.00 1.00 2.5 Billion 1.00
Total Non-Current Assets 3.08 Billion 2.71 Billion 2.71 Billion 2.65 Billion 2.52 Billion 2.38 Billion
Net PPE 2.4 Billion 2.33 Billion 2.32 Billion 2.33 Billion 2.3 Billion 2.28 Billion
Good Will And Intangible Assets 88.11 Million 104.17 Million 120.26 Million 136.18 Million 151.65 Million 36 Million
Good Will - - - - - -
Intangible Assets 88.11 Million 104.17 Million 120.26 Million 136.18 Million 151.65 Million 36 Million
Long-Term Investments 169.47 Million 50.48 Million 50.48 Million 50.47 Million 49.97 Million 49.97 Million
Tax Assets - - 218.11 Million 136.54 Million 6.93 Million 7.24 Million
Other Non Current Assets 421.58 Million 225.4 Million -2000.00 -1.00 10.75 Million 14.58 Million
Other Assets - - - - - -
Total Liabilities 2.7 Billion 2.19 Billion 1.99 Billion 1.76 Billion 1.72 Billion 1.38 Billion
Total Current Liabilities 2.62 Billion 2.16 Billion 1.96 Billion 1.73 Billion 1.69 Billion 1.36 Billion
Account Payables 432.96 Million 277.35 Million 550.87 Million 452.32 Million 682.05 Million 502.01 Million
Tax Payables 9.47 Million 2.8 Million 8.87 Million 25.31 Million 24.39 Million 5.24 Million
Short Term Debt 1.05 Billion 1.04 Billion 922.93 Million 959.13 Million 698.49 Million 576.42 Million
Deferred Revenue 9.47 Million 8.71 Million 429.17 Million 318.57 Million 299.11 Million 282.46 Million
Other Current Liabilities 1.12 Billion 830.37 Million 63.64 Million 1.00 16.52 Million 1.00
Total Non Current Liabilities 78.65 Million 31.7 Million 32.75 Million 32.27 Million 27.08 Million 23.92 Million
Long-Term Debt 48.65 Million 4.03 Million 6.64 Million 6.52 Million 2.99 Million 5.04 Million
Deferred Revenue Non Current - - - - 22.21 Million -4.11 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 30 Million 27.67 Million 26.1 Million 25.74 Million -2.99 Million 18.87 Million
Other Liabilities - - - - - -
Total Equity 6.09 Billion 5.73 Billion 5.41 Billion 6.13 Billion 5.57 Billion 5.07 Billion
Stock Holders Equity 6.09 Billion 5.73 Billion 5.41 Billion 6.13 Billion 5.57 Billion 5.07 Billion
Common Stock 190.04 Million 190.04 Million 190.04 Million 190.04 Million 190.04 Million 190.04 Million
Retained Earnings 4.41 Billion 4.05 Billion 3.74 Billion 4.45 Billion 3.89 Billion 3.39 Billion
Accumulated other comprehensive income 5.9 Billion 150.12 Million 149.92 Million 151.62 Million -180.72 Million -177.41 Million
Common Stock Equity 6.09 Billion 5.73 Billion 5.41 Billion 6.13 Billion 5.57 Billion 5.07 Billion
Capital Lease Obligation - - - - - -
Total Investments 169.47 Million 50.48 Million 50.63 Million 50.47 Million 49.97 Million 49.97 Million
Total Debt 1.1 Billion 1.05 Billion 929.58 Million 965.66 Million 701.49 Million 581.47 Million
Net Debt 329.36 Million 672.17 Million 887.9 Million 673.55 Million 481.69 Million 367.67 Million

Balance Sheet Charts